| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Immunology, Institute of Medical Microbiology and Hygiene, University of Freiburg, Freiburg, Germany; and
Department of Internal Medicine I (Hematology/Oncology), Freiburg University Medical Center, Freiburg, Germany
The identification of tumor-associated Ags recognized by CD8+ CTL and prevention of tumor outgrowth by adoptive transfer of these CTL demonstrates that CD8+ T cells play a major role in antitumor immunity. We have generated B16.F10 melanoma cells that express the glycoprotein epitope amino acid 33–41 (GP33) of the lymphocytic choriomeningitis virus (LCMV) to examine antitumor CD8+ T cell response in C57BL/6 mice immune to LCMV and in mice transgenic for the LCMV GP33-specific P14 TCR (P14 TCR mice). We find that B16.F10GP33 tumor cells grew in syngeneic C57BL/6 mice without inducing T cell tolerance. LCMV infection or adoptive transfer of LCMV-specific effector T cells delayed but did not prevent growth of preestablished tumors in these mice. However, B16.F10GP33 tumor cells were rejected in mice immune to LCMV and in mice treated with LCMV-specific effector T cells on the same day as the tumor. Surprisingly, B16.F10GP33 tumor cells grew in P14 TCR transgenic mice despite an abundance of tumor-associated Ag-specific CD8+ T cells. In these mice, freshly isolated tumor-infiltrating lymphocytes exhibited an activated phenotype and displayed high GP33-specific cytolytic activity when assessed ex vivo. Thus, B16.F10GP33 melanoma cells are able to initiate, but not to sustain, a GP33-specific CTL response sufficient to clear the tumor enduringly.
This article has been cited by other articles:
|
|
 |
|
  T. Suzuki, S. Ogawa, K. Tanabe, H. Tahara, R. Abe, and H. Kishimoto Induction of Antitumor Immune Response by Homeostatic Proliferation and CD28 Signaling J. Immunol., April 1, 2008; 180(7): 4596 - 4605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Monu and A. B. Frey Suppression of Proximal T Cell Receptor Signaling and Lytic Function in CD8+ Tumor-Infiltrating T Cells Cancer Res., December 1, 2007; 67(23): 11447 - 11454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Luketic, J. Delanghe, P. T. Sobol, P. Yang, E. Frotten, K. L. Mossman, J. Gauldie, J. Bramson, and Y. Wan Antigen Presentation by Exosomes Released from Peptide-Pulsed Dendritic Cells Is not Suppressed by the Presence of Active CTL J. Immunol., October 15, 2007; 179(8): 5024 - 5032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Weinhold, D. Sommermeyer, W. Uckert, and T. Blankenstein Dual T Cell Receptor Expressing CD8+ T Cells with Tumor- and Self-Specificity Can Inhibit Tumor Growth without Causing Severe Autoimmunity J. Immunol., October 15, 2007; 179(8): 5534 - 5542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Matter, V. Pavelic, D. D. Pinschewer, S. Mumprecht, B. Eschli, T. Giroglou, D. von Laer, and A. F. Ochsenbein Decreased Tumor Surveillance after Adoptive T-Cell Therapy Cancer Res., August 1, 2007; 67(15): 7467 - 7476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Hargadon, C. C. Brinkman, S. L. Sheasley-O'Neill, L. A. Nichols, T. N. J. Bullock, and V. H. Engelhard Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes J. Immunol., November 1, 2006; 177(9): 6081 - 6090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Otahal, T. D. Schell, S. C. Hutchinson, B. B. Knowles, and S. S. Tevethia Early Immunization Induces Persistent Tumor-Infiltrating CD8+ T Cells against an Immunodominant Epitope and Promotes Lifelong Control of Pancreatic Tumor Progression in SV40 Tumor Antigen Transgenic Mice. J. Immunol., September 1, 2006; 177(5): 3089 - 3099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ohta, E. Gorelik, S. J. Prasad, F. Ronchese, D. Lukashev, M. K. K. Wong, X. Huang, S. Caldwell, K. Liu, P. Smith, et al. A2A adenosine receptor protects tumors from antitumor T cells PNAS, August 29, 2006; 103(35): 13132 - 13137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Zoeteweij, D. E. Epperson, J. D. Porter, C. X. Zhang, O. Y. Frolova, A. P. Constantinides, S. R. Fuhrmann, M. El-Amine, J.-H. Tian, L. R. Ellingsworth, et al. GM1 Binding-Deficient Exotoxin Is a Potent Noninflammatory Broad Spectrum Intradermal Immunoadjuvant J. Immunol., July 15, 2006; 177(2): 1197 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. McWilliams, S. M. McGurran, S. W. Dow, J. E. Slansky, and R. M. Kedl A Modified Tyrosinase-Related Protein 2 Epitope Generates High-Affinity Tumor-Specific T Cells but Does Not Mediate Therapeutic Efficacy in an Intradermal Tumor Model J. Immunol., July 1, 2006; 177(1): 155 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Limmer, R Ganss, N Garbi, B Arnold, and G J Hammerling Stimulation of autoimmunity by toll-like receptor ligands Ann Rheum Dis, November 1, 2005; 64(suppl_4): iv15 - iv17. [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, N. Obholzer, R. Fayad, and L. Qiao Turning On/Off Tumor-Specific CTL Response during Progressive Tumor Growth J. Immunol., September 1, 2005; 175(5): 3110 - 3116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wei, I. Kryczek, L. Zou, B. Daniel, P. Cheng, P. Mottram, T. Curiel, A. Lange, and W. Zou Plasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma Cancer Res., June 15, 2005; 65(12): 5020 - 5026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koneru, D. Schaer, N. Monu, A. Ayala, and A. B. Frey Defective Proximal TCR Signaling Inhibits CD8+ Tumor-Infiltrating Lymphocyte Lytic Function J. Immunol., February 15, 2005; 174(4): 1830 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hirano, K. Kaneko, H. Tamura, H. Dong, S. Wang, M. Ichikawa, C. Rietz, D. B. Flies, J. S. Lau, G. Zhu, et al. Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity Cancer Res., February 1, 2005; 65(3): 1089 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lou, G. Wang, G. Lizee, G. J. Kim, S. E. Finkelstein, C. Feng, N. P. Restifo, and P. Hwu Dendritic Cells Strongly Boost the Antitumor Activity of Adoptively Transferred T Cells In vivo Cancer Res., September 15, 2004; 64(18): 6783 - 6790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Bartholomae, F. H. Rininsland, J. C. Eisenberg, B. O. Boehm, P. V. Lehmann, and M. Tary-Lehmann T Cell Immunity Induced by Live, Necrotic, and Apoptotic Tumor Cells J. Immunol., July 15, 2004; 173(2): 1012 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Salio, M. J. Palmowski, A. Atzberger, I. F. Hermans, and V. Cerundolo CpG-matured Murine Plasmacytoid Dendritic Cells Are Capable of In Vivo Priming of Functional CD8 T Cell Responses to Endogenous but Not Exogenous Antigens J. Exp. Med., February 17, 2004; 199(4): 567 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. O'Mara and P. M. Allen Pulmonary Tumors Inefficiently Prime Tumor-Specific T Cells J. Immunol., January 1, 2004; 172(1): 310 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. F. Hermans, T. W. Chong, M. J. Palmowski, A. L. Harris, and V. Cerundolo Synergistic Effect of Metronomic Dosing of Cyclophosphamide Combined with Specific Antitumor Immunotherapy in a Murine Melanoma Model Cancer Res., December 1, 2003; 63(23): 8408 - 8413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tahara, K. Fujio, Y. Araki, K. Setoguchi, Y. Misaki, T. Kitamura, and K. Yamamoto Reconstitution of CD8+ T Cells by Retroviral Transfer of the TCR {alpha}{beta}-Chain Genes Isolated from a Clonally Expanded P815-Infiltrating Lymphocyte J. Immunol., August 15, 2003; 171(4): 2154 - 2160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Krishnan, S. Sad, G. B. Patel, and G. D. Sprott Archaeosomes Induce Enhanced Cytotoxic T Lymphocyte Responses to Entrapped Soluble Protein in the Absence of Interleukin 12 and Protect against Tumor Challenge Cancer Res., May 15, 2003; 63(10): 2526 - 2534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Blohm, E. Roth, K. Brommer, T. Dumrese, F. M. Rosenthal, and H. Pircher Lack of Effector Cell Function and Altered Tetramer Binding of Tumor-Infiltrating Lymphocytes J. Immunol., November 15, 2002; 169(10): 5522 - 5530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dudani, Y. Chapdelaine, H. v. Faassen, D. K. Smith, H. Shen, L. Krishnan, and S. Sad Multiple Mechanisms Compensate to Enhance Tumor-Protective CD8+ T Cell Response in the Long-Term Despite Poor CD8+ T Cell Priming Initially: Comparison Between an Acute Versus a Chronic Intracellular Bacterium Expressing a Model Antigen J. Immunol., June 1, 2002; 168(11): 5737 - 5745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ganss, E. Ryschich, E. Klar, B. Arnold, and G. J. Hammerling Combination of T-Cell Therapy and Trigger of Inflammation Induces Remodeling of the Vasculature and Tumor Eradication Cancer Res., March 1, 2002; 62(5): 1462 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T. Nguyen, A. R. Elford, K. Murakami, K. M. Garza, S. P. Schoenberger, B. Odermatt, D. E. Speiser, and P. S. Ohashi Tumor Growth Enhances Cross-Presentation Leading to Limited T Cell Activation without Tolerance J. Exp. Med., February 11, 2002; 195(4): 423 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Perez-Diez, P. J. Spiess, N. P. Restifo, P. Matzinger, and F. M. Marincola Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance J. Immunol., January 1, 2002; 168(1): 338 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. N. Le, N. C. Lee, K. Tsung, and J. A. Norton Pre-Existing Tumor-Sensitized T Cells Are Essential for Eradication of Established Tumors by IL-12 and Cyclophosphamide Plus IL-12 J. Immunol., December 15, 2001; 167(12): 6765 - 6772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Radoja, M. Saio, D. Schaer, M. Koneru, S. Vukmanovic, and A. B. Frey CD8+ Tumor-Infiltrating T Cells Are Deficient in Perforin-Mediated Cytolytic Activity Due to Defective Microtubule-Organizing Center Mobilization and Lytic Granule Exocytosis J. Immunol., November 1, 2001; 167(9): 5042 - 5051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Radoja, M. Saio, and A. B. Frey CD8+ Tumor-Infiltrating Lymphocytes Are Primed for Fas-Mediated Activation-Induced Cell Death But Are Not Apoptotic In Situ J. Immunol., May 15, 2001; 166(10): 6074 - 6083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Dalyot-Herman, O. F. Bathe, and T. R. Malek Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC J. Immunol., December 15, 2000; 165(12): 6731 - 6737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Rawson, I. F. Hermans, S. P. Huck, J. M. Roberts, H. Pircher, and F. Ronchese Immunotherapy with Dendritic Cells and Tumor Major Histocompatibility Complex Class I-derived Peptides Requires a High Density of Antigen on Tumor Cells Cancer Res., August 1, 2000; 60(16): 4493 - 4498. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Oelke, U. Moehrle, J.-L. Chen, D. Behringer, V. Cerundolo, A. Lindemann, and A. Mackensen Generation and Purification of CD8+ Melan-A-specific Cytotoxic T Lymphocytes for Adoptive Transfer in Tumor Immunotherapy Clin. Cancer Res., May 1, 2000; 6(5): 1997 - 2005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Prevost-Blondel, E. Roth, F. M. Rosenthal, and H. Pircher Crucial Role of TNF-{alpha} in CD8 T Cell-Mediated Elimination of 3LL-A9 Lewis Lung Carcinoma Cells In Vivo J. Immunol., April 1, 2000; 164(7): 3645 - 3651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Radoja, T. D. Rao, D. Hillman, and A. B. Frey Mice Bearing Late-Stage Tumors Have Normal Functional Systemic T Cell Responses In Vitro and In Vivo J. Immunol., March 1, 2000; 164(5): 2619 - 2628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Dobrzanski, J. B. Reome, and R. W. Dutton Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases J. Immunol., June 1, 1999; 162(11): 6671 - 6680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Ochsenbein, P. Klenerman, U. Karrer, B. Ludewig, M. Pericin, H. Hengartner, and R. M. Zinkernagel Immune surveillance against a solid tumor fails because of immunological ignorance PNAS, March 2, 1999; 96(5): 2233 - 2238. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
